We make GLP-1 treatment accessible with transparent pricing, personalized dosing, and support when you need it
Tracking Progress and Adjusting Over Time Maintain a therapy journal to log: Daily dose and injection time Sleep onset and quality (110 scale) Energy and mood ratings Bi-weekly body weight and waist measurements Review trends with your provider after quarterly labs
Important note: some research suggests this dose should be discontinued after 2-4 months and should not be used continuously and without end
Weight, meals, water, protein, symptoms, and the weekly shot all live in one tracker, which matters when menopause makes the week feel noisier than usual
Secretagogue-induced release (CJC-1295/Ipamorelin): GH released in pulses, with peak amplitude during sleep-associated secretory windows Ipamorelin induces an acute GH pulse within 15-30 minutes of administration CJC-1295 (No DAC) extends GH elevation for approximately 30 minutes per pulse Combined administration produces amplified pulses documented in Bowers et al